Transactions

Our broad-based transaction experience extends across a range of situations, industries and enterprise values

Type

Industry

Royal DSM NV

Announced: May 31, 2022
Value: €40 billion
Status: Pending

Financial advisor to DSM on its merger with Firmenich

Biohaven Pharmaceutical Holding Company Ltd.

Announced: May 10, 2022
Value: $12.5 billion
Status: Closed

Exclusive financial advisor to Biohaven Pharmaceuticals on its sale to Pfizer Inc. and pro rata distribution of shares in a new publicly traded biopharma company

Intelsat S.A.

Announced: February 1, 2022
Value: $8 billion
Status: Pending

Exclusive investment banker to a group of ad hoc lenders throughout Intelsat's chapter 11 proceedings, including a refinancing of existing secured debt and DIP facilities

Cornerstone Building Brands, Inc.

Announced: February 14, 2022
Value: $5.9 billion
Status: Pending

Financial advisor to the Special Committee of Cornerstone's Board of Directors on the sale of shares to Clayton, Dubilier & Rice that CD&R did not already own

Global Blood Therapeutics, Inc.

Announced: August 8, 2022
Value: $5.8 billion
Status: Pending

Financial advisor to Global Blood Therapeutics on its sale to Pfizer

Royal DSM NV

Announced: May 31, 2022
Value: €3.85 billion
Status: Pending

Financial advisor to DSM on the sale of its DSM Engineering Materials business to a newly incorporated joint venture owned by Advent International and LANXESS AG

R1 RCM Inc.

Announced: January 10, 2022
Value: $4.1 billion
Status: Pending

Lead financial advisor to R1 on its acquisition of Cloudmed

Affinivax, Inc.

Announced: May 31, 2022
Value: Up to $3.3 billion
Status: Pending

Financial advisor to Affinivax on its sale to GSK plc

Informa plc

Announced: February 10, 2022
Value: £1.9 billion
Status: Closed

Financial advisor to Informa on the divestiture of its Pharma Intelligence business to Warburg Pincus

Ligue de Football Professionnel

Announced: April 1, 2022
Value: €1.5 billion
Status: Pending

Financial advisor to the LFP on the sale of a 13% minority stake in its newly-created MediaCo subsidiary to CVC

Pensando Systems

Announced: April 4, 2022
Value: $1.9 billion
Status: Pending

Exclusive financial advisor to Pensando on its acquisition by Advanced Micro Devices

Royal DSM NV

Announced: April 20, 2022
Value: €1.44 billion
Status: Pending

Financial advisor to DSM on its divestiture of its DSM Protective Materials business to Avient Corporation

Constellation Brands

Announced: June 30, 2022
Value: $1.5 billion
Status: Pending

Exclusive financial advisor to the Special Committee of the Board of Directors of Constellation in connection with the reclassification of Constellation's Class B common stock

I2PO

Announced: April 18, 2022
Value: €1.075 billion
Status: Pending

Financial advisor to I2PO, a Special Purpose Acquisition Company (SPAC) on its acquisition of Deezer

Forma Therapeutics, Inc.

Announced: September 1, 2022
Value: $1.1 billion
Status: Pending

Exclusive financial advisor to Forma Therapeutics on its sale to Novo Nordisk

Convey Health Solutions Holdings, Inc.

Announced: June 21, 2022
Value: $1.1 billion
Status: Pending

Sole financial advisor to the Special Committee of the Board of Directors of Convey on the sale of remaining shares not currently owned by TPG Capital to TPG

Stanley Black & Decker

Announced: April 22, 2022
Value: $900 million
Status: Pending

Exclusive financial advisor to Stanley on the divestiture of Access Technologies, its automatic doors business, to Allegion plc

2MX Organic S.A.

Announced: March 31, 2022
Value: €675 million
Status: Pending

Financial advisor to 2MX Organic, a Special Purpose Acquisition Company (SPAC), on its combination with InVivo Retail

Resideo Technologies, Inc.

Announced: February 7, 2022
Value: $593 million
Status: Pending

Exclusive financial advisor to Resideo on its acquisition of First Alert, Inc. from Newell Brands Inc.

Revlon, Inc.

Announced: June 15, 2022
Value: $575 million
Status: Pending

Exclusive investment banker to the BrandCo Ad-Hoc Group in connection with Revlon's chapter 11 filing with the support of a debtor-in-possession financing provided by BrandCo lenders

ReViral Inc.

Announced: April 7, 2022
Value: Up to $525 million
Status: Pending

Financial advisor to ReViral on its sale to Pfizer Inc.

Dhanani Group, Inc.

Announced: June 10, 2022
Value: $500 million
Status: Pending

Financial advisor to DGI on its balance sheet refinancing for its Burger King, Popeyes and La Madeleine operations

Chimerix

Announced: May 16, 2022
Value: Up to $337 million
Status: Closed

Exclusive financial advisor to Chimerix on its sale of exclusive worldwide rights to brincidofovir, including TEMBEXA, to Emergent BioSolutions

ViaCyte, Inc.

Announced: July 11, 2022
Value: $320 million
Status: Pending

Exclusive financial advisor to ViaCyte on its acquisition by Vertex Pharmaceuticals, Inc.

Oscar Health, Inc.

Announced: January 27, 2022
Value: $305 million
Status: Pending

Financial advisor to Oscar on its exploration of strategic financing alternatives and sole placement agent on a private placement of convertible senior notes led by Dragoneer Investment Group

PTC Inc

Announced: April 20, 2022
Value: $280 million
Status: Pending

Exclusive financial advisor to PTC on its acquisition of Intland Software

Checkmate Pharmaceuticals

Announced: April 19, 2022
Value: $250 million
Status: Pending

Exclusive financial advisor to Checkmate on its sale to Regeneron Pharmaceuticals

Cornerstone OnDemand, Inc.

Announced: June 13, 2022
Value: $200 million
Status: Pending

Exclusive financial advisor to Cornerstone, a portfolio company of Clearlake Capital, on its acquisition of SumTotal, a subsidiary of Skillsoft

Informa plc

Announced: July 19, 2022
Value: $193 million
Status: Pending

Financial advisor to Informa on its divestiture of EPFR Global to Montagu

Diageo plc

Announced: May 10, 2022
Value: £119 million
Status: Pending

Financial advisor to Diageo on its sale of Picon to Campari Group

Servicesource International, Inc.

Announced: May 9, 2022
Value: $150 million
Status: Closed

Exclusive financial advisor to ServiceSource on its acquisition by Concentrix Corporation

LogicBio Therapeutics, Inc.

Announced: October 3, 2022
Value: $70 million
Status: Pending

Exclusive financial advisor to LogicBio on its sale to by AstraZeneca through its subsidiary Alexion

Xperi Inc.

Announced: October 3, 2022
Status: Closed

Exclusive financial advisor to Xperi on its separation from Adeia, formerly Xperi Holding Corporation

TreeHouse Foods, Inc.

Announced: August 11, 2022
Value: $950 mi8llion
Status: Closed

Financial advisor to the Board of Directors of TreeHouse Foods on the divestiture of a significant portion of its Meal Preparation business to InvestIndustrial

Celsius Network LLC

Announced: July 13, 2022
Status: Pending

Investment banker to Celsius on its initiation of voluntary chapter 11 proceedings

The North Road Company

Announced: July 6, 2022
Status: Closed

Financial advisor to North Road on its combination of Chernin Entertainment, the US assets of Red Arrow Studios and Words + Pictures, in addition to an equity investment by Providence Equity Partners and debt financing from Apollo Advisors

Enjoy Technology, Inc.

Announced: June 30, 2022
Status: Pending

Exclusive financial advisor to Enjoy on its chapter 11 filing with debtor-in-possession financing provided by Asurion and connected letter of intent for Asurion to acquire substantially all of Enjoy's U.S. assets through a 363 sale process

Joseph Phelps Vineyards, Inc.

Announced: June 29, 2022
Status: Pending

Lead financial advisor to Joseph Phelps on its sale to Moët Hennessy, a division of LVMH

eBay Inc.

Announced: June 22, 2022
Status: Closed

Financial advisor to eBay on its acquisition of KnownOrigin

Accor SA

Announced: June 21, 2022
Status: Pending

Financial advisor to Accor on its sale of a 10.8% interest in Ennismore to Qatar First Bank

McDonald's Corporation

Announced: May 26, 2022
Status: Closed

Sole financial advisor to McDonald's in connection with its proxy contest with Icahn Enterprises

US Foods Holding Corp.

Announced: May 10, 2022
Status: Pending

Financial advisor to US Foods on its engagement with Sachem Head

MediaMath, Inc.

Announced: April 21, 2022
Status: Closed

Financial advisor and investment banker to MediaMath on its comprehensive recapitalization in partnership with Searchlight

Synovus Bank

Announced: April 21, 2022
Status: Pending

Financial Advisor to Synovus on its strategic investment to acquire 60% of Qualpay

Vauban Infrastructure Partners

Announced: March 9, 2022
Status: Pending

Exclusive financial advisor to Vauban on its purchase of equity in Paprec Group

Kimberly-Clark Corporation

Announced: February 24, 2022
Status: Closed

Exclusive financial advisor to Kimberly-Clark on its acquisition of a majority stake in Thinx, Inc.

Recipharm AB

Announced: February 18, 2022
Status: Closed

Exclusive financial advisor to Recipharm on its acquisition of Vibalogics

Recipharm AB

Announced: February 18, 2022
Status: Closed

Exclusive financial advisor to Recipharm on its acquisition of Arranta Bio

Resonant Inc.

Announced: February 14, 2022
Status: Closed

Lead financial advisor to Resonant on its purchase by Murata Manufacturing Co., Ltd.

Ole Smoky Distillery

Announced: February 11, 2022
Status: Closed

Financial advisor to Ole Smoky on its sale to Apax Partners

Thirty Madison

Announced: February 9, 2022
Status: Pending

Exclusive financial advisor to Thirty Madison on its merger with Nurx

Jacobs Engineering Group Inc.

Announced: February 7, 2022
Status: Pending

Exclusive financial advisor to Jacobs on its acquisition of StreetLight Data, Inc.

Centerview Partners takes a “One Firm” approach to deliver unmatched intellectual capital and integrity to all of our clients. We have industry-leading expertise in:

At Centerview Partners, our success depends on our people, and we are always looking for talented individuals. Please let us know if you would like to learn more about a career at Centerview.
Our Partners have worked on many of the largest and most complex transactions and corporate situations around the globe over the course of their careers. Learn more about who we are.